Large-scale mapping of human protein-protein interactions by mass spectrometry.

Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07

Defining the human deubiquitinating enzyme interaction landscape. Cell (2009) 11.39

High-quality binary protein interaction map of the yeast interactome network. Science (2008) 10.65

An empirical framework for binary interactome mapping. Nat Methods (2008) 6.59

Protein networks in disease. Genome Res (2008) 5.65

Regulatory networks define phenotypic classes of human stem cell lines. Nature (2008) 4.98

A human functional protein interaction network and its application to cancer data analysis. Genome Biol (2010) 4.73

The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods (2013) 4.34

A census of human soluble protein complexes. Cell (2012) 3.90

Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol (2010) 3.65

A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A (2008) 3.57

SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat Methods (2010) 3.50

Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature (2012) 3.37

A protein complex network of Drosophila melanogaster. Cell (2011) 3.31

Probabilistic assembly of human protein interaction networks from label-free quantitative proteomics. Proc Natl Acad Sci U S A (2008) 3.23

PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol (2011) 3.22

Tissue specificity and the human protein interaction network. Mol Syst Biol (2009) 3.20

The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog (2008) 3.11

An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol Syst Biol (2009) 2.92

Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature (2010) 2.91

Proteomics: a pragmatic perspective. Nat Biotechnol (2010) 2.81

MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev (2009) 2.67

A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol Cell Proteomics (2008) 2.56

PhosphoPep--a phosphoproteome resource for systems biology research in Drosophila Kc167 cells. Mol Syst Biol (2007) 2.56

MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev (2009) 2.49

iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence. Database (Oxford) (2010) 2.47

Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network. Genome Biol (2009) 2.43

Diverse roles and interactions of the SWI/SNF chromatin remodeling complex revealed using global approaches. PLoS Genet (2011) 2.38

Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6. Sci Signal (2009) 2.26

ProHits: integrated software for mass spectrometry-based interaction proteomics. Nat Biotechnol (2010) 2.22

Systems biology in immunology: a computational modeling perspective. Annu Rev Immunol (2011) 2.15

Protein analysis by shotgun/bottom-up proteomics. Chem Rev (2013) 2.13

CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics (2007) 2.11

A probabilistic generative model for GO enrichment analysis. Nucleic Acids Res (2008) 2.01

Interactome3D: adding structural details to protein networks. Nat Methods (2012) 1.89

Rewirable gene regulatory networks in the preimplantation embryonic development of three mammalian species. Genome Res (2010) 1.81

Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes. Mol Cell Proteomics (2010) 1.77

Unraveling protein networks with power graph analysis. PLoS Comput Biol (2008) 1.77

Streamlined analysis schema for high-throughput identification of endogenous protein complexes. Proc Natl Acad Sci U S A (2010) 1.72

VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networks. Nucleic Acids Res (2008) 1.71

3did: identification and classification of domain-based interactions of known three-dimensional structure. Nucleic Acids Res (2010) 1.71

Identifying causal genes and dysregulated pathways in complex diseases. PLoS Comput Biol (2011) 1.65

HAPPI: an online database of comprehensive human annotated and predicted protein interactions. BMC Genomics (2009) 1.61

Parallel visualization of multiple protein complexes in individual cells in tumor tissue. Mol Cell Proteomics (2013) 1.60

PrePPI: a structure-informed database of protein-protein interactions. Nucleic Acids Res (2012) 1.59

Predicting genetic modifier loci using functional gene networks. Genome Res (2010) 1.59

A high-throughput approach for measuring temporal changes in the interactome. Nat Methods (2012) 1.55

Role of STRAP in regulating GSK3β function and Notch3 stabilization. Cell Cycle (2011) 1.54

A map of human protein interactions derived from co-expression of human mRNAs and their orthologs. Mol Syst Biol (2008) 1.53

Enhancing the prioritization of disease-causing genes through tissue specific protein interaction networks. PLoS Comput Biol (2012) 1.51

A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability. Mol Cell (2010) 1.50

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol (2010) 1.47

Quantitative interaction proteomics using mass spectrometry. Nat Methods (2009) 1.47

A novel proteomics approach for the discovery of chromatin-associated protein networks. Mol Cell Proteomics (2008) 1.42

A complex-based reconstruction of the Saccharomyces cerevisiae interactome. Mol Cell Proteomics (2009) 1.42

A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency. Mol Cell Proteomics (2010) 1.41

INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol Syst Biol (2012) 1.40

Toward accurate reconstruction of functional protein networks. Mol Syst Biol (2009) 1.40

Natural selection in a bangladeshi population from the cholera-endemic ganges river delta. Sci Transl Med (2013) 1.39

The human-bacterial pathogen protein interaction networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis. PLoS One (2010) 1.38

Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. PLoS One (2011) 1.38

SPIKE--a database, visualization and analysis tool of cellular signaling pathways. BMC Bioinformatics (2008) 1.35

The MMS22L-TONSL complex mediates recovery from replication stress and homologous recombination. Mol Cell (2010) 1.32

Discovering pathways by orienting edges in protein interaction networks. Nucleic Acids Res (2010) 1.32

PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA. J Biol Chem (2010) 1.32

PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. J Biol Chem (2008) 1.31

Molecular evolution of the junctophilin gene family. Physiol Genomics (2009) 1.31

Dosage sensitivity shapes the evolution of copy-number varied regions. PLoS One (2010) 1.30

Towards the prediction of protein interaction partners using physical docking. Mol Syst Biol (2011) 1.30

A discovery resource of rare copy number variations in individuals with autism spectrum disorder. G3 (Bethesda) (2012) 1.30

ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genet (2011) 1.28

DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology (2010) 1.27

Purification and characterization of HIV-human protein complexes. Methods (2010) 1.26

Protein complex evolution does not involve extensive network rewiring. PLoS Comput Biol (2008) 1.25

High-resolution mapping of the protein interaction network for the human transcription machinery and affinity purification of RNA polymerase II-associated complexes. Methods (2009) 1.24

Establishment of a protein frequency library and its application in the reliable identification of specific protein interaction partners. Mol Cell Proteomics (2009) 1.24

A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem (2010) 1.23

MOB control: reviewing a conserved family of kinase regulators. Cell Signal (2011) 1.21

Computational and informatics strategies for identification of specific protein interaction partners in affinity purification mass spectrometry experiments. Proteomics (2012) 1.21

Subnetwork state functions define dysregulated subnetworks in cancer. J Comput Biol (2011) 1.21

SAINT-MS1: protein-protein interaction scoring using label-free intensity data in affinity purification-mass spectrometry experiments. J Proteome Res (2012) 1.20

Evidence mining and novelty assessment of protein-protein interactions with the ConsensusPathDB plugin for Cytoscape. Bioinformatics (2010) 1.19

Defining the budding yeast chromatin-associated interactome. Mol Syst Biol (2010) 1.19

InSite: a computational method for identifying protein-protein interaction binding sites on a proteome-wide scale. Genome Biol (2007) 1.18

A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One (2010) 1.17

Rab10 associates with primary cilia and the exocyst complex in renal epithelial cells. Am J Physiol Renal Physiol (2010) 1.16

Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest (2012) 1.16

Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity. EMBO J (2010) 1.14

Desmosomes at a glance. J Cell Sci (2009) 1.14

Interaction of FLASH with arsenite resistance protein 2 is involved in cell cycle progression at S phase. Mol Cell Biol (2009) 1.13

Profiling of protein interaction networks of protein complexes using affinity purification and quantitative mass spectrometry. Mol Cell Proteomics (2010) 1.13

In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology (2009) 1.13

The emerging paradigm of network medicine in the study of human disease. Circ Res (2012) 1.12

Large-scale de novo prediction of physical protein-protein association. Mol Cell Proteomics (2011) 1.11

Visualization and biochemical analyses of the emerging mammalian 14-3-3-phosphoproteome. Mol Cell Proteomics (2011) 1.11

Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system. Microbiol Mol Biol Rev (2012) 1.11

High-precision frequency measurements: indispensable tools at the core of the molecular-level analysis of complex systems. Anal Bioanal Chem (2007) 1.10

ARS2 is a conserved eukaryotic gene essential for early mammalian development. Mol Cell Biol (2007) 1.10

Dual role of ancient ubiquitous protein 1 (AUP1) in lipid droplet accumulation and endoplasmic reticulum (ER) protein quality control. J Biol Chem (2011) 1.10

Inhibition of Borna disease virus replication by an endogenous bornavirus-like element in the ground squirrel genome. Proc Natl Acad Sci U S A (2014) 1.10

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 45.19

Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 37.66

Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76

Comparative assessment of large-scale data sets of protein-protein interactions. Nature (2002) 24.25

A human protein-protein interaction network: a resource for annotating the proteome. Cell (2005) 18.97

The HUPO PSI's molecular interaction format--a community standard for the representation of protein interaction data. Nat Biotechnol (2004) 16.08

A map of the interactome network of the metazoan C. elegans. Science (2004) 15.60

The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci U S A (1991) 15.52

Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic Acids Res (2005) 9.90

Coexpression analysis of human genes across many microarray data sets. Genome Res (2004) 9.38

Protein interactions: two methods for assessment of the reliability of high throughput observations. Mol Cell Proteomics (2002) 8.11

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23

Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet (2001) 7.16

Analyzing yeast protein-protein interaction data obtained from different sources. Nat Biotechnol (2002) 7.06

Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature (2005) 6.69

Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci U S A (2001) 5.80

Comprehensive curation and analysis of global interaction networks in Saccharomyces cerevisiae. J Biol (2006) 5.57

The molecular mechanics of eukaryotic translation. Annu Rev Biochem (2004) 5.21

High-throughput mapping of a dynamic signaling network in mammalian cells. Science (2005) 5.21

Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". Genome Res (2001) 5.10

Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J (1995) 4.83

Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome. Genome Biol (2005) 3.79

A first-draft human protein-interaction map. Genome Biol (2004) 3.64

Reporting protein identification data: the next generation of guidelines. Mol Cell Proteomics (2006) 3.50

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45

Peroxisome biogenesis disorders. Biochim Biophys Acta (2006) 3.06

Release of initiation factors from 48S complexes during ribosomal subunit joining and the link between establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP. Genes Dev (2004) 2.88

A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol (2004) 2.38

Structure and interactions of the translation initiation factor eIF1. EMBO J (1999) 2.24

The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J Biol Chem (2003) 2.18

Never say never. The NIMA-related protein kinases in mitotic control. Trends Cell Biol (2003) 2.13

Partial nuclear pore complex disassembly during closed mitosis in Aspergillus nidulans. Curr Biol (2004) 2.10

Evidence for a NIMA-like mitotic pathway in vertebrate cells. Cell (1995) 1.92

Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol Cell Biol (1998) 1.92

Nercc1, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression. Genes Dev (2002) 1.87

A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases. J Biol Chem (2003) 1.75

Nek2 kinase in chromosome instability and cancer. Cancer Lett (2005) 1.75

Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett (1995) 1.56

Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors. Gene (2004) 1.52

Mammalian translation initiation factor eIF1 functions with eIF1A and eIF3 in the formation of a stable 40 S preinitiation complex. J Biol Chem (2002) 1.51

LYAR, a novel nucleolar protein with zinc finger DNA-binding motifs, is involved in cell growth regulation. Genes Dev (1993) 1.44

Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA (2005) 1.40

Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J Biol Chem (1999) 1.39

Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy? Biol Cell (2003) 1.23

Confirmation of human protein interaction data by human expression data. BMC Bioinformatics (2005) 1.23

Further biochemical and kinetic characterization of human eukaryotic initiation factor 4H. J Biol Chem (1999) 1.23

The SONB(NUP98) nucleoporin interacts with the NIMA kinase in Aspergillus nidulans. Genetics (2003) 1.17

Mass spectrometry for the study of protein-protein interactions. Methods (2001) 1.17

Genotype-phenotype correlations in disorders of peroxisome biogenesis. Mol Genet Metab (1999) 1.14

The human EMAP-like protein-70 (ELP70) is a microtubule destabilizer that localizes to the mitotic apparatus. J Biol Chem (2001) 1.11

Human adrenoleukodystrophy protein and related peroxisomal ABC transporters interact with the peroxisomal assembly protein PEX19p. Biochem Biophys Res Commun (2000) 1.07

Identification and characterization of Nek6 protein kinase, a potential human homolog of NIMA histone H3 kinase. Biochem Biophys Res Commun (2002) 0.96

Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 37.66

Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature (2006) 24.29

ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med (2010) 13.07

The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91

Systematic discovery of in vivo phosphorylation networks. Cell (2007) 6.94

PreBIND and Textomy--mining the biomedical literature for protein-protein interactions using a support vector machine. BMC Bioinformatics (2003) 6.31

From RNA-seq reads to differential expression results. Genome Biol (2010) 5.77

Histone recognition and large-scale structural analysis of the human bromodomain family. Cell (2012) 5.15

Alternative expression analysis by RNA sequencing. Nat Methods (2010) 5.02

Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem (2009) 4.95

Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters. Nat Genet (2002) 4.68

The Orbitrap: a new mass spectrometer. J Mass Spectrom (2005) 4.39

The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods (2013) 4.34

Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21

High-definition macromolecular composition of yeast RNA-processing complexes. Mol Cell (2004) 4.18

Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood (2010) 4.02

Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat Protoc (2013) 4.00

Genome-wide analysis of mRNA stability using transcription inhibitors and microarrays reveals posttranscriptional control of ribosome biogenesis factors. Mol Cell Biol (2004) 3.72

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45

A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell (2006) 3.38

Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell (2012) 3.21

Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol (2003) 3.20

Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature (2002) 3.15

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev (2002) 3.13

A panoramic view of yeast noncoding RNA processing. Cell (2003) 3.11

The synthetic genetic interaction spectrum of essential genes. Nat Genet (2005) 3.06

A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell (2010) 2.95

NetworKIN: a resource for exploring cellular phosphorylation networks. Nucleic Acids Res (2007) 2.69

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathol (2011) 2.64

Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. Value Health (2003) 2.61

Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood (2010) 2.60

Functional genomics and proteomics: charting a multidimensional map of the yeast cell. Trends Cell Biol (2003) 2.46

Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nat Genet (2012) 2.45

Identifying transcription factor functions and targets by phenotypic activation. Proc Natl Acad Sci U S A (2006) 2.39

Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol (2010) 2.38

Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature (2013) 2.33

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int (2005) 2.29

Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood (2003) 2.29

Predictive adaptive responses to maternal high-fat diet prevent endothelial dysfunction but not hypertension in adult rat offspring. Circulation (2004) 2.28

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol (2011) 2.27

Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med (2011) 2.25

ProHits: integrated software for mass spectrometry-based interaction proteomics. Nat Biotechnol (2010) 2.22

Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex. PLoS Biol (2006) 2.17

Genome-wide analysis of mouse transcripts using exon microarrays and factor graphs. Nat Genet (2005) 2.15

Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. Am J Hum Genet (2011) 2.12

Modification of the Creator recombination system for proteomics applications--improved expression by addition of splice sites. BMC Biotechnol (2006) 2.01

WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol (2005) 1.97

Isothermal whole genome amplification from single and small numbers of cells: a new era for preimplantation genetic diagnosis of inherited disease. Mol Hum Reprod (2004) 1.93

Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell (2012) 1.91

Polymer-based elemental tags for sensitive bioassays. Angew Chem Int Ed Engl (2007) 1.88

Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc (2004) 1.85

Rapid evolution of functional complexity in a domain family. Sci Signal (2009) 1.85

High-resolution genetic mapping with ordered arrays of Saccharomyces cerevisiae deletion mutants. Genetics (2002) 1.78

Defining the specificity space of the human SRC homology 2 domain. Mol Cell Proteomics (2007) 1.78

Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA. Genome Res (2012) 1.78

A systematic review of postgraduate teaching in evidence-based medicine and critical appraisal. Med Teach (2003) 1.77

Ynamides: a modern functional group for the new millennium. Chem Rev (2010) 1.77

Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics (2011) 1.76

Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011. Perit Dial Int (2011) 1.76

Differential analysis of membrane proteins in mouse fore- and hindbrain using a label-free approach. J Proteome Res (2006) 1.71

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer (2012) 1.70

The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol Cell Proteomics (2007) 1.70

Assessments in evidence-based medicine workshops: loose connection between perception of knowledge and its objective assessment. Med Teach (2001) 1.63

Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study. Radiology (2005) 1.63

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc Natl Acad Sci U S A (2014) 1.59

Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A (2005) 1.57

Quantitative mass spectrometry of DENV-2 RNA-interacting proteins reveals that the DEAD-box RNA helicase DDX6 binds the DB1 and DB2 3' UTR structures. RNA Biol (2011) 1.54

Transcriptional networks: reverse-engineering gene regulation on a global scale. Curr Opin Microbiol (2004) 1.54

HysTag--a novel proteomic quantification tool applied to differential display analysis of membrane proteins from distinct areas of mouse brain. Mol Cell Proteomics (2003) 1.52

The proteomic reactor: a microfluidic device for processing minute amounts of protein prior to mass spectrometry analysis. J Proteome Res (2006) 1.51

Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. Mol Cell Biol (2003) 1.50

Glycoproteomic reactor for human plasma. J Proteome Res (2009) 1.49

Mechanism of Mos1 transposition: insights from structural analysis. EMBO J (2006) 1.48

Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2. J Mol Cell Biol (2011) 1.48

Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat Chem Biol (2006) 1.47

Serum- and glucocorticoid-regulated kinase 1 regulates ubiquitin ligase neural precursor cell-expressed, developmentally down-regulated protein 4-2 by inducing interaction with 14-3-3. Mol Endocrinol (2005) 1.46

Repitools: an R package for the analysis of enrichment-based epigenomic data. Bioinformatics (2010) 1.45

Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci (2004) 1.44

Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry. Proteomics (2007) 1.43

Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making. BJOG (2003) 1.43

Differential gene expression in the siphonophore Nanomia bijuga (Cnidaria) assessed with multiple next-generation sequencing workflows. PLoS One (2011) 1.43

A strategy for modulation of enzymes in the ubiquitin system. Science (2013) 1.43